CDC Launches National Viral Genomics Consortium to Better Map SARS-CoV-2 Transmission
The Centers for Disease Control and Prevention {(CDC) Atlanta, GA, USA} has kicked off the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES) consortium, which will expand the use of whole genome sequencing (WGS) of the COVID-19 virus. More...04 May 2020
Gilead’s Remdesivir Receives US FDA Emergency Use Authorization for Treatment of COVID-19
Gilead Sciences’ (Foster City, CA, USA) investigational antiviral drug remdesivir has been granted emergency use authorization (EUA) to treat COVID-19 by the US Food and Drug Administration (FDA). More...04 May 2020
Arthritis Drug in Clinical Trial for Potentially Treating COVID-19 Related Pneumonia
Researchers at the Virginia Commonwealth University (Richmond, VA, USA) have joined a study for testing the efficacy of sarilumab, a drug already approved by the FDA to treat arthritis, in reducing inflammation in the lungs in patients with coronavirus-related pneumonia. More...04 May 2020
Front Line COVID-19 Critical Care Consortium Recommends Early Delivery of Anti-Inflammatory Therapies
A group of five critical care specialists have jointly released a protocol for treating COVID-19 patients who are brought to hospitals, urging the immediate adoption of early intervention protocol to prevent mortality and reduce the need for ventilators. More...04 May 2020
Avacta and Adeptrix Collaborate to Develop Coronavirus Antigen Test Using Mass Spectrometry
Avacta Group plc (Wetherby, England) has entered into a collaboration with Adeptrix (Beverly, MA, USA) to develop a high throughput COVID-19 antigen test using Adeptrix’s proprietary bead-assisted mass spectrometry (BAMS) platform. More...04 May 2020
Gilead’s Remdesivir Accelerates Recovery from Advanced COVID-19 in NIH Clinical Trial
Preliminary data analysis from a randomized, controlled trial has found that hospitalized patients with advanced COVID-19 and lung involvement who received Gilead Sciences’ (Foster City, CA, USA) remdesivir recovered faster than similar patients who received placebo. More...02 May 2020
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Documentation System For Blood Banks
HettInfo II
New
Fetal and Maternal Monitor
F9 Series
In Other News
Clinical Trial to Study Effects of Steroid-Cannabidiol (CBD) Treatment on Hospitalized COVID-19 Patients
New Study to Assess Effectiveness of Inhaled Nitric Oxide as Treatment for SARS in COVID-19 Patients
Researchers Develop Inexpensive Disposable Ventilator to Treat COVID-19 Patients
Moderna Signs 10-Year Deal with Lonza for Manufacturing One Billion COVID-19 Vaccine Doses per Year
Bio-Rad’s SARS-CoV-2 Serology Test Becomes First Total COVID Antibody Test to Secure FDA EUA
Aalto Bio Launches Lysis Buffer Reagent for COVID-19 Testing
altona Diagnostics Receives Emergency Use Authorization from US FDA for RealStar SARS-CoV-2 RT-PCR Kit US
NIH’s RADx Initiative to Speed Development of Rapid and Widely Accessible COVID-19 Testing
AstraZeneca Enters into Landmark Agreement with Oxford University for COVID-19 Vaccine
Personal Ventilation Hood for Hospital Beds Contains Droplet Spread of Coronavirus in ICUs
BillionToOne COVID-19 Test with 30X Higher Throughput Could Unlock Millions of Daily Testing Capacity Worldwide
Serologic Testing Helps Scientists Connect Dots on COVID-19 Clusters
Study of COVID-19 POC Tests Finds Antibody Tests Can Complement PCR Diagnostics
Rheonix Receives FDA Emergency Use Authorization for Rapid, Fully Automated Molecular COVID-19 Test
US ‘Operation Warp Speed’ To Ready 300 Million Vaccine Doses by End Of 2020
SEASUN BIOMATERIALS Launches COVID-19 Rapid Molecular Assay
Pfizer and BioNTech Complete Dosing for First Cohort of Phase 1/2 trial of COVID-19 Vaccine Candidates in Germany
Largest COVID-19 Study of Hospitalized Patients in US Links Comorbidities to Acuity
Mindray Launches New ME Series Portable Ultrasound Systems to Combat COVID-19
Harvard-Designed Injection-Molded Nasopharyngeal Swabs For COVID-19 Enter Human Trials
COVID-19 Vaccine Delivered Via Dermal Patch Applied to Skin Begins Pre-Clinical Testing
University of Queensland’s COVID-19 Vaccine Demonstrates Strong Antibody Response to Neutralize Coronavirus in Pre-Clinical Testing
Gilead Reports Positive Data from Phase 3 Trial of Remdesivir in Patients with Severe COVID-19
